STUDY BRIEF | To develop novel tools and classification algorithms to identify the relative contribution of multiple pain mechanisms in individual patients to enhance diagnosis of vulvodynia and choice of tailored, mechanistic-based treatments.
Study Brief | The purpose of the ACE trial is to assess cognitive function in women taking an anticholinergic medication (trospium) for the treatment of overactive bladder. This medication is FDA-approved and is not experimental. There are rare reports of changes in cognitive function when taking any anticholinergic medication for overactive bladder. The goal is to administer written cognitive function tests to measure your cognitive function before and after starting medication.
Study Brief: The purpose of this research study is to compare vaginal mesh and suture exposure rates in women undergoing robotic total hysterectomy and sacrocolpopexy with a light-weight polypropylene mesh (Upsylon™ y-mesh) using permanent (2-0 polytetrafluoroethylene, Gore-Tex) versus delayed absorbable monofilament (2-0 polydioxanone, PDS) sutures at 1-year.
STUDY BRIEF | To explore the relative contribution of the mucosal and muscle pain sensitivity to clinical pain report among women with vestibulodynia.
Study Brief | The purpose of this research study is to determine genes that affect how a person’s body metabolizes a drug can help us predict how women will respond to a FDA approved medication (fesoterodine fumarate) for urgency urinary incontinence (UUI).
You are invited to help UNC researchers understand how infant feeding affects weight gain, inflammation and cardiovascular activity during the first postpartum year.
You are invited to help UNC researchers understand how breastfeeding builds bonds between mothers and babies.
STUDY BRIEF | Time to Conceive is a research study that hopes to find a way to accurately measure a woman’s fertility. Women between 30 and 44 years of age who are trying to become pregnant or about to start trying are eligible to participate in the study. Women are not eligible to participate if they or their partner have a history of infertility or fertility treatment.